Literature DB >> 29469695

Cutaneous Balamuthia mandrillaris infection as a precursor to Balamuthia amoebic encephalitis (BAE) in a healthy 84-year-old Californian.

Larisa M Lehmer1, Gabriel E Ulibarri, Bruce D Ragsdale, James Kunkle.   

Abstract

Soil and freshwater-dwelling amoebae may opportunistically infect the skin and evoke a granulomatous dermatitis that camouflages their underlying morphology. Amoebic infestations are incredibly rare in the U.S., predominantly occurring in the young, elderly, and immunocompromised. Sadly, because diagnosis is difficult and unsuspected, most cases are diagnosed at autopsy. The following case is of a healthy 84-year-old man with a non-healing nodulo-ulcerative cutaneous lesion on his left forearm that appeared following a gardening injury. Lesional punch biopsies repeatedly showed non-specific granulomatous inflammation with no pathogens evident histologically or by culture. Histopathologic diagnosis was made five months after initial presentation via identification of amoebic trophozoite forms in tissue from a large excisional specimen. Anti-amoebic therapy was initiated immediately. The patient experienced mental status changes three days following lesion excision, with evidence of a cystic mass in the left medial parieto-occipital lobe by CT. Both intraoperative brain biopsies and cutaneous tissue samples tested positive for Balamuthia mandrillaris by indirect immunofluorescent antibody assay performed at the Centers for Disease Control. The patient achieved a full recovery on a triple antibiotic regimen. Clinical suspicion and thorough histopathologic analysis may determine the difference between survival and death for a patient presenting with a treatment-refractory localized granulomatous lesion.

Entities:  

Mesh:

Year:  2017        PMID: 29469695

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  6 in total

1.  Subacute Balamuthia mandrillaris encephalitis in an immunocompetent patient diagnosed by next-generation sequencing.

Authors:  Changbo Xu; Xiaoyan Wu; Miaoqin Tan; Dongmei Wang; Shengnan Wang; Yongming Wu
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

2.  Rapid, Noninvasive Diagnosis of Balamuthia mandrillaris Encephalitis by a Plasma-Based Next-Generation Sequencing Test.

Authors:  Gautam Kalyatanda; Kenneth Rand; Martin S Lindner; David K Hong; Mehmet Sait Albayram; Jason Gregory; Jesse Kresak; Karim M Ali Ibne; Jennifer R Cope; Shantanu Roy; Joy M Gary; Varalakshmi Reddy; Asim A Ahmed
Journal:  Open Forum Infect Dis       Date:  2020-06-01       Impact factor: 3.835

3.  A patient with granulomatous amoebic encephalitis caused by Balamuthia mandrillaris survived with two excisions and medication.

Authors:  Limei Peng; Quan Zhou; Yu Wu; Xiaoli Cao; Zili Lv; Minghua Su; Yachun Yu; Wen Huang
Journal:  BMC Infect Dis       Date:  2022-01-15       Impact factor: 3.090

Review 4.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

5.  Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris.

Authors:  Matthew T Laurie; Corin V White; Hanna Retallack; Wesley Wu; Matthew S Moser; Judy A Sakanari; Kenny Ang; Christopher Wilson; Michelle R Arkin; Joseph L DeRisi
Journal:  mBio       Date:  2018-10-30       Impact factor: 7.867

6.  Cutaneous balamuthiasis: A clinicopathological study.

Authors:  Patricia Alvarez; Carlos Torres-Cabala; Eduardo Gotuzzo; Francisco Bravo
Journal:  JAAD Int       Date:  2022-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.